Oregon officials have reached a $2.3 million settlement with a generic drug manufacturer from India over allegations that it sold improperly manufactured prescription drugs in Oregon.
The Oregon Department of Justice says it filed the settlement Tuesday with Ranbaxy Laboratories and two affiliated U.S. companies. Officials say no Oregonians are known to have been harmed by the drugs, and all the products are now off the market.
As part of the settlement, five state agencies that purchased the allegedly adulterated drugs will receive a full refund.
Ranbaxy must also pay $1.4 million to the Department of Justice's consumer protection fund, and $540,000 to the Board of Pharmacy.
Oregon's settlement follows a 2013 federal and state government settlement with Ranbaxy for $500 million. Oregon was the lead state in the settlement.